Inhibition of human glioblastoma cell adhesion and invasion by 4-(4'- hydroxylphenyl)-amino-6,7-dimethoxyquinazoline (WHI-P131) and 4-(3'-bromo- 4'-hydroxylphenyl)amino-6,7-dimethoxyquinazoline (WHI-P154)

Clinical Cancer Research

Volumn 4, Issue 10, 1998, Pages 2463-2471

  Narla, Rama Krishna ^a   Liu, Xing Ping ^a   Klis, Daniel ^a   Uckun, Fatih M ^a  

^a Department of Genetics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3' BROMO 4' HYDROXYPHENYL)AMINO 6,7 DIMETHOXYQUINAZOLINE; 4 (4 HYDROXYANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 (4' HYDROXYPHENYL)AMINO 6,7 DIMETHOXYQUINAZOLINE; QUINAZOLINE DERIVATIVE; UNCLASSIFIED DRUG; WHI P 154;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER INVASION; CELL ADHESION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ACTINS; ANTINEOPLASTIC AGENTS; CELL ADHESION; EPIDERMAL GROWTH FACTOR; GLIOBLASTOMA; HUMANS; INTEGRINS; NEOPLASM INVASIVENESS; QUINAZOLINES; TUMOR CELLS, CULTURED;

EID: 0031755916     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Russel, D. C., and Rubinstein, L. Tumors of central neuroepithelial orisin. In: E. Arnold (ed.), Pathology of Tumors of the Nervous System, Ed. 5., pp. 83-289. London: Hodder & Stoughton, 1989.
2. Devaux, B. C., O'Fallon, J. R., and Kelly, P. J. Resection, biopsy, and survival in malignant glial neoplasm. J. Neurosurg., 78: 767-775, 1993.
3. Kreth, F. W., Warnke, P. C., Scherement, R., Ostertag, C. B. Surgical resection and radiotherapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J. Neurosurg., 78: 762-766, 1993.
4. Quigley, M. R., and Maroon, J. C. The relationship between survival and the extent of the resection in patients with supratentorial malignant gliomas. Neurosurgery, 29: 385-389, 1991.
5. Berens, M. E., Rutka, J. T., and Rosenblum, M. L. Brain tumor epidemiology, and invasion. Neurosurg. Clin. N. Am., 1: 1-18, 1990.
6. Chintala, S. K., Hokaslan, Z. L., Go, Y., Sawaya, R., Nicolson, G. L., and Rao, J. S. Role of extracellular matrix proteins in regulation of human glioma cell invasion. Clin. Exp. Metastasis. 14: 358-366, 1996.
7. Finlay, J. L. Chemotherapeutic strategies for high grade astrocytoma of childhood. In: R. J. Packer, W. A. Bleyer, and C. Pochedly (eds.), Pediatric Neuro-Oncology, pp. 278-297. Philadelphia: Harwood Academics, 1992.
8. Grossman, S. A., and Norris, L. K. Adjuvant and neoadjuvant treatments for primary brain tumors in adults. Semin. Oncol., 22: 530-539, 1995.
9. Pardos, M. D., and Russo, C. Chemotherapy of brain tumors. Semin. Surg. Oncol., 14: 88-95, 1998.
10. Brandes, A. A., and Fiorentino, M. V. The role of chemotherapy in recurrent malignant gliomas: an overview. Cancer Invest., 14: 551-559, 1996.
11. Pardos, M. D., and Wilson, C. B. Neoplasms of the central nervous system. In: J. F. Holland, R. C. Bast, Jr., D. L. Morton, E. Frei, III, D. W. Kufe, and R. R. Weichselbaum (eds.), Cancer Medicine, Vol I, pp. 1471-1514. Baltimore: Williams and Wilkins, 1997.
12. Narla, R. K., Liu, X., Myers, D. E., and Uckun, F. M. 4-(3′-Bromo-4′hydroxylphenyl)-amino-6,7-dimethoxyquinazoline (WHI-P154): a novel quinazoline derivative with potent cytotoxic activity against human glioblastoma cells. Clin. Cancer Res., 4: 1405-1414, 1998.
13. Nomoto, F., Obase, H., Takai, H., Hirata, T., Teranishi, M., Nakamura, J., and Kubo, K. Studies on cardiotic agents. I. Synthesis of quinazoline derivatives. Chem. Pharm. Bull., 38: 1591-1595, 1990.
14. Thomas, C. L. Catalytic Processes and Proven Catalysts. New York: Academic Press, 1970.
15. Yoshida, D., Piepmeier, J. M., and Teramoto, A. In vitro inhibition, of cell proliferation, viability, and invasiveness in U87MG human glioblastoma cells by estramustine phosphate. Neurosurgery, 39: 360-366, 1996.
16. Carbonetto, S. The extracellular matrix of the central nervous system. Trends Neurosci., 7: 382-387, 1984.
17. Rutka, J. T., Apodaca, G., and Stern, R. The role of extracellular matrix of the central and peripheral nervous system: structure and function. J. Neurosurg., 69: 155-170, 1988.
18. Venstrom, K. A., and Reichard, L. F. Extracellular matrix 2: role of extracellular matrix molecules and their receptors in the nervous system. FASEB J., 7: 996-1003, 1993.
19. Hatai, M., Hashi, H., Mogi, A., Soga, H., Yokota, J., and Yaoi, Y. Stimulation of tyrosine- and serine-phosphorylation of focal adhesion kinase in mouse 3T3 cells by fibronectin and fibroblast growth factor. FEBS Lett., 350: 113-116, 1994.
20. Ouwens, D. M., Mikkers, H. M., van der Zon, G. C., Stein Gerlach, M., Ullrich, A., and Maassen, J. A. Insulin-induced tyrosine dephosphorylation of paxillin and focal adhesion kinase requires active phosphotyrosine phosphatase 1D. Biochem. J., 318: 609-614, 1996.
21. Schaller, M. D., and Parsons, J. T. Focal adhesion kinase and associated proteins. Curr. Opin. Cell Biol., 6: 705-710, 1994.
22. Zachary, I. Focal adhesion kinase. Int. J. Biochem. Cell Biol., 29: 929-934, 1997.
23. Rohde-Schulz, B., and Lichtner, R. B. EGF enhances attachment of metastatic rat mammary adenocarcinoma cell clone MTLn3 to fibronectin and collagen. Invasion Metastasis, 15: 1-10, 1995.
24. Sato, M., Narita, T., Kawakami-Kimura N., Higashiyama, S., Taniguchi, N., Akiyama, S., Hashimoto, T., Manabe, T., and Kannagi, R. Increase expression of integrins by heparin-binding EGF like growth, factors in esophageal cancer cells. Cancer Lett., 102: 183-194, 1996.
25. Price, J. T., Wilson, H. M., and Haites, N. E. Epidermal growth factor (EGF) increases the in vitro invasion, motility and adhesion interactions of the primary renal carcinoma cell line, A704. Eur. J. Cancer, 32: 1977-1982, 1996.
26. Solic, N., and Davies, D. E. Differential effects of EGF and amphiregulin on adhesion molecule expression and migration of colon carcinoma cells. Exp. Cell Res., 234: 465-476, 1997.
27. Symons, M. H., and Mitchison, T. J. Control of actin polymerization in live and permeabilized fibroblasts. J. Cell Biol., 114: 503-513, 1991.
28. Wang, Y. L. Reorganization of actin filament bundles in living fibroblasts. J. Cell Biol., 99: 1478-1485, 1984.
29. Bretcher, M. S. Getting membrane flow and the cytoskeleton to cooperate in moving cells. Cell, 87: 601-606, 1996.
30. Machesky, L. M., and Hall, A. Role of actin polymerization and adhesion to extracellular matrix in Rac- and Rho-induced cytoskeletal reorganization. J. Cell Biol., 138: 913-926, 1997.
31. Burridge, K., Path, K., Kelly, G., and Turner, C. Focal adhesions: transmembrane junctions between the extracellular matrix and the cytoskeleton. Annu. Rev. Cell Biol., 4: 487-525, 1988.
32. Burridge, K., Nuckolls, C., Otey, F., Pavalko, K., Simon, K., and Turner, C. Actin membrane interaction in focal adhesion. Cell Differ. Dev., 32: 337-342, 1990.
33. Burridge, K., and Fath, K. Focal contacts: transmembrane links between the extracellular matrix and cytoskeleton. Bioessays. 10: 104-108, 1989.
34. Schwarzbauer, J. E. Cell migration: may the force be with you. Curr. Biol., 7: 292-294, 1997.
35. Finchman, V. J., and Frame, M. C. The activity of Src is dispensable for translocation to focal adhesions but controls the turnover of these structures during cell motility. EMBO J., 17: 81-92, 1998.
36. Cobb, B. S., Schaller, M. D., Leu, T. H., and Parsons, J. T. Stable association of pp60src and pp59fyn with the focal adhesion-associated protein tyrosine kinase, pp125FAK. Mol. Cell. Biol., 14: 147-155, 1994.
37. Chen, Q., Lin, T. H., Der, C. J., and Juliano, R. L. Integrin-mediated activation of MEK and mitogen-activated protein kinase is independent of Ras. J. Biol. Chem., 271: 18122-18127, 1996.
38. Klemke, R. L., Cai, S., Giannini, A. L., Gallagher, P. J., Lanerolle, P. D., and Cheresh, D. A. Regulation of cell motility by mitogen-activated protein kinase. J. Cell Biol., 137: 481-492, 1997.
39. Fetch, L. A., Bockholt, S. M., Bouton, A., Parsons, J. T., and Burridge, K., Adhesion-induced tyrosine phosphorylation of the p130 src substrate. J. Cell Sci., 108: 1371-1379, 1995.
40. Chrzanowska-Wodnicka, M., and Burridge, K. Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J. Cell Biol., 133: 1403-1415, 1996.
41. Miyamoto, S., Akiyama, S. K., and Yamada, K. M. Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science (Washington DC), 267: 883-885, 1995.
42. Miyamoto, S., Teramoto, H., Gutkind, J. S., and Yamada, K. M. Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and activation of receptors. J. Cell Biol., 135: 1633-1642, 1996.
43. Chen, H. C., Appeddu, P. A., Parsons, J. T., Hildebrand, J. D., Schaller, M. D., and Guan, J. L. Interaction of focal adhesion kinase with cytoskeletal protein talin. J. Biol. Chem., 270: 16995-16999, 1995.
44. Fry, D. W., Kraker, A., McMichael, A., Ambroso, L. A., Nelson, J. M., Leopold, W. R., Connors, R. W., and Bridges, A. L. A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science (Washington DC), 265: 1093-1095, 1994.
45. Bos, M., Mendelsohn, J., Kim, Y., Albanell, J., Fry, D. W., and Baselga, J. PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner. Clin. Cancer Res., 3: 2099-2106, 1997.